SZodixStudyAcademic Library
DashboardShelvesOpen accessMy libraryInboxNotesWriteLearnAlerts
More
Ask your libraryNotificationsQuick citeReview
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Health Technology Assessment and Health Policy-Making in Europe: Current Status, Challenges and Potential
0 references·8 citing·28 second hop
Health Technology Assessment and Health Policy-Making in Europe: Current Status, Challenges and Potential (2009)Health Technology Assessment and Health P…Guidance from key organisations on exploring, confirming and interpreting subgroup effects of medical treatments: a scoping review (2019)Guidance from key organisatio…Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA (2018)Identifying the Need for Good…Methods of international health technology assessment agencies for economic evaluations- a comparative analysis (2013)Methods of international heal…Preserving General Interest in Healthcare Through Secondary and Soft EU Law: The Case of the Patients’ Rights Directive (2012)Preserving General Interest i…The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries (2010)The role of health technology…Practical tools and methods for health technology assessment in Europe: Structures, methodologies, and tools developed by the European network for Health Technology Assessment, EUnetHTA (2009)Practical tools and methods f…European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment (2009)European network for Health T…Developing Health Technology Assessment to address health care system needs (2009)Developing Health Technology …Economics of Health Care Financing: The Visible Hand (1993)Financing health care in the European Union: challenges and policy responses (2009)Learning From Experience (2023)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Cost-Benefit Analysis (2020)Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation (2005)Flawed but fair: Brazil’s health system reaches out to the poor (2008)Pharmaceutical Policy In China (2008)MAPPING OF HEALTH TECHNOLOGY ASSESSMENT IN SELECTED COUNTRIES (2013)Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts (2016)Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE (2017)BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTS (2002)The development of health technology assessment (2003)Evidence based policy making (2004)The HTA Core Model: A novel method for producing and reporting health technology assessments (2009)SIMILARITIES AND DIFFERENCES BETWEEN FIVE EUROPEAN DRUG REIMBURSEMENT SYSTEMS (2012)HTA Implementation Roadmap in Central and Eastern European Countries (2016)Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups (2007)The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016)Automated hospital pharmacy supply chain and the evaluation of organisational impacts and costs (2020)An Integrated Framework to Measure the Performance of Inter-Organizational Programme on Health Technology Assessment (2021)Cochrane Handbook for Systematic Reviews of Interventions (2008)Scoping studies: advancing the methodology (2010)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions (2012)Early market access of cancer drugs in the EU (2015)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2018Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA123 cited
  • 2009European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment106 cited
  • 2010The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries97 cited
  • 2009Practical tools and methods for health technology assessment in Europe: Structures, methodologies, and tools developed by the European network for Health Technology Assessment, EUnetHTA88 cited
  • 2013Methods of international health technology assessment agencies for economic evaluations- a comparative analysis87 cited
  • 2009Developing Health Technology Assessment to address health care system needs87 cited
  • 2012Preserving General Interest in Healthcare Through Secondary and Soft EU Law: The Case of the Patients’ Rights Directive21 cited
  • 2019Guidance from key organisations on exploring, confirming and interpreting subgroup effects of medical treatments: a scoping review17 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work